Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for Inflammation-Induced Glutamate Changes in Depression
NCT03004443Phase 4Terminated
- Sponsor
- Emory University
- Start
- May 2017
- Primary completion
- Nov 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in major depressive disorder (MDD), sponsored by Emory University. Started May 2017; status: terminated.
02
Drugs
infliximab
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03004443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03004443.